Andere talen Gubra A/S

Aandelen

GUBRA

DK0062266474

Beurs gesloten - Nasdaq Copenhagen Andere beurzen 16:59:36 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
311 ^DKK	-2,81%		+4,01%	+148,80%

17/04	Gubra onthult UCN2 als nieuw kandidaat-geneesmiddel tegen obesitas voor gezond gewichtsverlies	CI
26/01	Gubra sluit onderzoeksovereenkomst af met Silence Therapeutics plc	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss	17/04
Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	29/03
Gubra Concludes the Research Agreement with Silence Therapeutics plc	26/01
Gubra and Boehringer Ingelheim Sign 4Th Partnership, Expanding Their Successful Obesity Treatment Discovery Collaboration	13/12
Gubra A/S Announces First Subject Dosed in Phase 1 Clinical Trial of Amylin Agonist for the Treatment of Obesity	29/11
Gubra A/S Announces Board Appointments	01/11
Gubra Raises Earnings Guidance for Full-Year 2023	26-10-23
Denmark's Gubra Opens First US Office Under Expansion Strategy	24-10-23
Gubra A/S Opens Its First US Office in Boston	24-10-23
Gubra Seeks UK Regulatory Approval to Begin Human Trial for Anti-Obesity Drug	06-09-23
Gubra A/S Submits Clinical Trial Application for First-In-Human Amylin Trial	06-09-23
Tranche Update on Gubra A/S's Equity Buyback Plan announced on June 30, 2023.	25-08-23
Gubra Announces Termination of Collaboration with Bayer AG	23-08-23
Gubra A/S Raises Financial Guidance for Full-Year 2023	15-08-23
Gubra A/S commences an Equity Buyback Plan for 1,180,424 shares, under the authorization approved on March 16, 2023.	30-06-23
Gubra A/S acquired Minigut Aps for DKK 5.96 million.	29-06-23
Gubra A/S Announces Updates to Its Pipeline	09-06-23
Gubra A/S and Boehringer Ingelheim Share Phase 1 Results for BI 1820237	17-05-23
Gubra A/S Provides Revenue Guidance for the Year 2023	11-05-23
Danish Biotech Gubra's IPO Overallotment Option Partly Exercised	02-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Gubra A/S

Aandelen

GUBRA

DK0062266474

Andere talen

Filters